D82-27087-62478
3 vaccinations
11 coded responses
24 check-ins
11 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 078 / NJ
- Registered
- 2021-04-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-20
Dose 1 — Pfizer-BioNTech
-
2021-04-21
Registered in v-safe
-
2021-04-21
Survey response — days 1–6 daily, dose 1MedDRA: Chest pain — Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Chest painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-24
Survey response — days 1–6 daily, dose 1MedDRA: Asthenia, Dizziness — Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Dizziness, weaknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
-
2021-04-27
Health check-in — day 7, dose 1Feeling: Good · Site: Pain, Itching · Joint pains, Muscle or body aches, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-06
Survey response — day 14, dose 1MedDRA: Pain, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activitiesFree text: Some worsening of pre existing chronic pain.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-11
Dose 2 — Pfizer-BioNTech
-
2021-05-11
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Fever · Fatigue or tirednessAdult check-in
-
2021-05-12
Survey response — days 1–6 daily, dose 2MedDRA: Syncope — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: FaintingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Survey response — days 1–6 daily, dose 2MedDRA: Blindness transient, Dizziness, Lymphadenopathy, Vision blurred — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: Swollen lymph nodes, feeling faint, brief vision loss/blurringMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-14
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy, Tachycardia — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesFree text: Tachycardia, swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-17
Survey response — days 1–6 daily, dose 2MedDRA: Syncope — Feeling: Fair · Headache, Fatigue or tirednessFree text: Fainting episodeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-18
-
2021-05-25
Survey response — day 14, dose 2MedDRA: Dysmenorrhoea, Menstrual disorder, Self-medication — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Abnormal symptoms during menstruation (no/very little flow and periods of extreme pain not controlled by multiple pain medications and heat when they usually are)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-01
- 2021-06-08
-
2021-06-15
Survey response — day 35, dose 2MedDRA: Abdominal pain, Acne, Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Worsening abdominal pain, acne, and hidradenitis suppurtivaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-22
Survey response — day 42, dose 2MedDRA: Pain, Pre-existing disease, Tachycardia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Worsening chronic pain and tachycardiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-10
- 2021-11-09
-
2022-03-27
Dose 3 — Pfizer-BioNTech
- 2022-05-02
-
2022-05-08
Survey response — day 42, dose 3MedDRA: Condition aggravated, Hypersensitivity, Pre-existing disease — Feeling: PoorFree text: Worsened allergies and Hidradenitis Suppurativa flare up.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-20 | Pfizer-BioNTech | |
| 2 | 2021-05-11 | Pfizer-BioNTech | |
| 3 | 2022-03-27 | Pfizer-BioNTech | No |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Chest pain
Systemic reaction (other): Dizziness, weakness
Release 8 — day 14, dose 1
Symptoms: Some worsening of pre existing chronic pain.
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Fainting
Systemic reaction (other): Swollen lymph nodes, feeling faint, brief vision loss/blurring
Systemic reaction (other): Tachycardia, swollen lymph nodes
Systemic reaction (other): Fainting episode
Release 8 — day 14, dose 2
Symptoms: Abnormal symptoms during menstruation (no/very little flow and periods of extreme pain not controlled by multiple pain medications and heat when they usually are)
Release 9 — day 35, dose 2
Symptoms: Worsening abdominal pain, acne, and hidradenitis suppurtiva
Release 9 — day 42, dose 2
Symptoms: Worsening chronic pain and tachycardia
Release 11 — day 42, dose 3
Symptoms: Worsened allergies and Hidradenitis Suppurativa flare up.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | ✓ | ✓ | ✓ |
| SD | Acne | ✓ | ✓ | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Dysmenorrhoea | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SD | Tachycardia | ✓ | ✓ | ✓ |
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Blindness transient | ✓ | ✓ | ✓ |
| SRO | Chest pain | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Syncope | ✓ | ✓ | ✓ |
| SRO | Tachycardia | ✓ | ✓ | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release